Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds
    Journal Article

    Siddiqui, R.; Onel, K.; Facio, F.; Nafa, K.; Diaz, L. R.; Kauff, N.; Huang, H.; Robson, M.; Ellis, N.; Offit, K.
    Familial Cancer (2005)

    Fulltext@MSK | Save
  • Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer
    Journal Article

    Seidman, A. D.
    Breast Diseases: A Year Book Quarterly (2005)

    Fulltext@MSK | Save
  • Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: Focus on cardiac safety
    Journal Article

    Seidman, A. D.
    Breast Diseases: A Year Book Quarterly (2005)

    Fulltext@MSK | Save
  • Current status of dose-dense chemotherapy for breast cancer
    Journal Article

    Seidman, A. D.
    Cancer Chemotherapy and Pharmacology (2005)

    Fulltext@MSK | Save
  • "Will weekly work"? Seems to be so
    Journal Article

    Seidman, A. D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series
    Journal Article

    Robson, M.; Svahn, T.; McCormick, B.; Borgen, P.; Hudis, C. A.; Norton, L.; Offit, K.
    Cancer (2005)

    Fulltext@MSK | Save
  • The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers - Commentary
    Journal Article

    Robson, M.
    Women's Oncology Review (2005)

    Fulltext@MSK | Save
  • Conceptual and practical implications of breast tissue geometry: Toward a more effective, less toxic therapy
    Journal Article

    Norton, L.
    The Oncologist (2005)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
    Journal Article

    Muss, H. B.; Woolf, S.; Berry, D.; Cirrincione, C.; Weiss, R. B.; Budman, D.; Wood, W. C.; Henderson, I. C.; Hudis, C.; Winer, E.; more...
    JAMA - Journal of the American Medical Association (2005)

    Fulltext@MSK | Save
  • Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer
    Journal Article

    Morris, M. J.; Cordon-Cardo, C.; Kelly, W. K.; Slovin, S. F.; Siedlecki, K.; Regan, K. P.; DiPaola, R. S.; Rafi, M.; Rosen, N.; Scher, H. I.
    Applied Immunohistochemistry & Molecular Morphology (2005)

    Fulltext@MSK | Save